A NEW GENE THERAPY
FOR SOME AGGRESSIVE
TYPES OF LYMPHOMA.
THE TREATMENT IS
GIVING HOPE TO
PATIENTS WHO HAVE
RUN OUT OF OPTIONS.
DR. MALLIKA MARSHALL
HAS MORE FROM
BOSTON.
59 YEAR OLD JUDY
WILKINS BATTLED
LYMPHOMA FOR YEARS.
THE CANCER GOT SO
AGGRESSIVE, MULITPLE
ROUNDS OF
CHEMOTHERAPY DID
NOT HELP AND SHE WAS
NOT A CANDIDIATE FOR A
STEM CELL TRANSPLANT.
SOT JUDY
WILKINS/LYMPHOMA
PATIENTI NEVER REALLY
THOUGHT AT THAT POINT
IT WOULD BE MAKING
CHOICES ON MY LIFE.
BUT THEN THE MORE I
REALIZED HOW SICK I
REALLY WAS BECAUSE I
WAS IN TOTAL DENIAL
ABOUT IT AND THAT'S
WHEN CARON SAID WE
ARE DOING THISDR.
CARON JACOBSON FROM
THE DANA FARBER
CANCER INSTITUTE IN
BOSTON TOLD JUDY
ABOUT AN
EXPERIMENTAL
TREATMENT... CAR T
CELL THERAPY. A
PATIENT'S OWN IMMUNE
CELLS KNOWN AS "T"
CELLS ARE ENGINEERED
TO FIND AND KILL
CANCER CELLS. CAR T
IS CUSTOM MADE FOR
EACH PATIENT AND
DELIVERED ONCE.SOT
DR. CARON JACOBSON/
DANA FARBER CANCER
INSTITUTEWE GIVE THEM
SOME GENTLE
CHEMOTHERAPY FOR A
COUPLE OF DAYS IN
ORDER TO HELP T CELLS
GROW BETTER ONCE WE
GET THEM BACK INTO
PATIENT AND THEN WE
INFUSE PATIENT WITH
CELLS AND WE WAIT FOR
THEM TO DO THEIR JOB
BRIDGE DR. MALLIKA
MARSHALL/CBS NEWSIN
A NATIONWIDE CLINICAL
TRIAL, OF THE 101
PATIENTS WHO
UNDERWENT
TREATMENT WITH CAR-T ,
84% HAD A RESPONSE.
54% HAD A COMPLETE
RESPONSE AND WENT
INTO REMISSION,
INCLUDING JUDY.SOT
DR. CARON JACOBSON/
DANA FARBER CANCER
INSTITUTETHIS IS A
TREMENDOUS DEAL
THE TREATMENT COSTS
HUNDREDS OF
THOUSAND OF DOLLARS.
IT CAN CAUSE SERIOUS
SIDE EFFECTS AND
THREE PEOPLE DIED
AFTER GETTING THE
THE TREATMENT COSTS
HUNDREDS OF
THOUSAND OF DOLLARS.
IT CAN CAUSE SERIOUS
SIDE EFFECTS AND
THREE PEOPLE DIED
AFTER GETTING THE
TREATMENT.
THE FDA IS REQUIRING A
LONG TERM SAFETY
STUDY AS WELL
TRAINING FOR
HOSPITALS TO QUICKLY
SPOT AND MANAGE
REACTIONS.
